The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Adenosine receptors in regulation of dendritic cell differentiation and function
Open accessAbstract
Differentiation of functional dendritic cells (DCs) critically depends on the microenvironment. DCs differentiate in hypoxic tumor sites and inflamed or damaged tissue. Because local concentrations of adenosine reach high physiologically relevant levels in these conditions, we assessed the expression of adenosine receptors and the effect of their activation on differentiation of human monocytes and mouse peritoneal macrophages and hematopoietic progenitor cells (HPCs) into myeloid DCs. Stimulation of adenosine receptors skews DC differentiation toward a distinct cell population characterized by expression of both DC and monocyte/macrophage cell surface markers. Pharmacologic analysis and experiments with cells from A2B adenosine receptor knockout mice identified A2B receptor as the mediator of adenosine effects on DCs. Unlike normal myeloid DCs, adenosine-differentiated DCs have impaired allostimulatory activity and express high levels of angiogenic, pro-inflammatory, immune suppressor, and tolerogenic factors, including VEGF, IL-8, IL-6, IL-10, COX-2, TGF-β, and IDO. They promoted tumor growth if injected into tumors implanted in mice. Using adenosine desaminase knockout animals, we showed that DCs with proangiogenic phenotype are highly abundant under conditions associated with elevated levels of extracellular adenosine in vivo. Adenosine signaling through A2B receptor is an important factor of aberrant DC differentiation and generation of tolerogenic, angiogenic, and proinflammatory cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The engagement of adenosine 2A receptor (A2AR) with adenosine elicits immunoinhibitory effects: suppressing the activities of tumor-infiltrating CD8+ T cells and hampering the function and differentiation of DCs [333, 334].”
From Combination strategies with PD-1/PD-L1 blockade: current advances and future directions (2022) · cites this paper as [333]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,962
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,028
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D. E., Wong, M. K. K., Huang, X., Caldwell, S. A., Liu, K., Smith, P. T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,095
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 900
Zea, A. H., Rodrı́guez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D. F., Quiceno, D. G., Youmans, A. J., O’Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 852
Adenosine, an endogenous anti-inflammatory agent
Cronstein, B. N. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.1.5 · Cited by 633
Fredholm, B. B., Irenius, E., Kull, B., & Schulte, G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00570-0 · Cited by 430
A model of angiogenesis in the mouse cornea.
Kenyon, B. M., Voest, E. E., Chen, C. C., Flynn, E. A., Folkman, J., & D’Amato, R. J. (1996) · PubMed · Cited by 403
Reppert, S. M., Weaver, D. R., Stehle, J. H., & Rivkees, S. A. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-8-1037 · Cited by 336
Adenosine in Bronchoalveolar Lavage Fluid in Asthma
Driver, A. G., Kukoly, C. A., Ali, S., & Mustafa, S. J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.1.91 · Cited by 307
Pinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G.-J., & Leibovich, S. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63698-x · Cited by 278
RDC8 codes for an adenosine A2 receptor with physiological constitutive activity
Maenhaut, C., SANDE, J. V., Libert, F., Abramowicz, M. J., Parmentier, M., Vanderhaegen, J.-J., Dumont, J. E., Vassart, G., & Schiffmann, S. N. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80909-x · Cited by 271
Pacheco, R., Martinez-Navío, J. M., Lejeune, M., Climent, N., Oliva, H., Gatell, J. M., Gallart, T., Mallol, J., Lluís, C., & Franco, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501050102 · Cited by 244
Differentiation of Langerhans cells in Langerhans cell histiocytosis
Geissmann, F., Lepelletier, Y., Fraitag, S., Valladeau‐Guilemond, J., Bodemer, C., Debré, M., Leborgne, M., Saeland, S., & Brousse, N. (2001) · Blood · doi:10.1182/blood.v97.5.1241 · Cited by 237
Panther, E., Corinti, S., Idzko, M., Herouy, Y., Napp, M., la Sala, A., Girolomoni, G., & Norgauer, J. (2003) · Blood · doi:10.1182/blood-2002-07-2113 · Cited by 229
Blackburn, M. R., Volmer, J. B., Thrasher, J. L., Zhong, H., Crosby, J. R., Lee, J. J., & Kellems, R. E. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.159 · Cited by 204
Self-citationExpression and function of adenosine receptors in human dendritic cells
Panther, E., Idzko, M., Herouy, Y., Rheinen, H., Gebicke‐Haerter, P. J., Mrowietz, U., Dichmann, S., & Norgauer, J. (2001) · The FASEB Journal · doi:10.1096/fj.01-0169com · Cited by 190
Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma
Huszár, É., Vass, G., Vizi, É., Csoma, Z., Barát, E., Világos, G. M., Herjavecz, I., & Horváth, I. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00005002 · Cited by 184
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation
Munn, D. H. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.01.002 · Cited by 177
IL-6 Production by Pulmonary Dendritic Cells Impedes Th1 Immune Responses
Dodge, I. L., Carr, M. W., Cernadas, M., & Brenner, M. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4457 · Cited by 168
The sponge/Matrigel angiogenesis assay
Akhtar, N., Dickerson, E. B., & Auerbach, R. (2002) · Angiogenesis · doi:10.1023/a:1021507031486 · Cited by 160
Characterization of Murine Lung Dendritic Cells Infected withMycobacterium tuberculosis
Juarrero, M. G., & Orme, I. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.1127-1133.2001 · Cited by 150
Langerhans-cell histiocytosis 'insight into DC biology'
Laman, J. D. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00063-2 · Cited by 147
Cloning and functional characterization of a human Al adenosine receptor
Libert, F., SANDE, J. V., Lefort, A., Czernilofsky, A. P., Dumont, J. E., Vassart, G., Ensinger, H. A., & Mendla, K. D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91285-x · Cited by 120
Dendritic cells in asthma: a function beyond sensitization
van Rijt, L. S., & Lambrecht, B. N. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02321.x · Cited by 90
Targeting Tumor-Related Immunosuppression for Cancer Immunotherapy
Frumento, G., Piazza, T., Carlo, E. D., & Ferrini, S. (2006) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153006778250019 · Cited by 89
RFL9 encodes an A2b-adenosine receptor.
Rivkees, S. A., & Reppert, S. M. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.10.1333049 · Cited by 84
Xaus, J., Valledor, A. F., Cardó, M., Marqués, L., Beleta, J., Palacios, J. M., & Celada, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4140 · Cited by 83
Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction
Csoma, Z., Huszár, É., Vizi, É., Vass, G., Szabó, Z., Herjavecz, I., Kollai, M., & Horváth, I. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00110204 · Cited by 74
Feoktistov, I., Garland, E. M., Goldstein, A. E., Zeng, D., Belardinelli, L., Wells, J. N., & Biaggioni, I. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00765-1 · Cited by 67
Self-citationDendritic cells have the option to express IDO-mediated suppression or not
Munn, D. H., Mellor, A. L., Rossi, M., & Young, J. W. (2005) · Blood · doi:10.1182/blood-2005-01-0122 · Cited by 55
Najar, H. M., Rühl, S., Bru-Capdeville, A. C., & Peters, J. H. (1990) · Journal of Leukocyte Biology · doi:10.1002/jlb.47.5.429 · Cited by 55
Effects of calcium channel blockers on cellular apoptosis
Mason, R. P. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990515)85:10 · Cited by 47
Hofer, S., Ivarsson, L., Stoitzner, P., Auffinger, M., Romani, N., Heufler, C., & Rainer, C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12369.x · Cited by 47
Giordano, D., Magaletti, D. M., Clark, E. A., & Beavo, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6421 · Cited by 38
Norrby, K., & Ridell, B. (2003) · Apmis · doi:10.1034/j.1600-0463.2003.1110406.x · Cited by 33
Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay
Baker, J. H. E., Huxham, L. A., Kyle, A. H., Lam, K. K., & Minchinton, A. I. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.01.002 · Cited by 21
A purinergic hypothesis for immunomodulation.
Virgilio, F. D., Mutini, C., Chiozzi, P., Falzoni, S., Di Susino, M., Sanz, J. M., & Ferrari, D. (1996) · PubMed · Cited by 4
Blais (1997) · doi:10.1002/1529-0131(199707)40:7
Research works printed but not linked: 1
- Merrill, 1997, Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis., Arthritis Rheum, 40, 1308
Cited by
Sorted by citations
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
CD4 T cells: fates, functions, and faults
Zhu, J., & Paul, W. E. (2008) · Blood · doi:10.1182/blood-2008-05-078154 · Cited by 1,915
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Yi, M., Zheng, X., Niu, M., Zhu, S., Ge, H., & Wu, K. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01489-2 · Cited by 1,445
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Targeting immunosuppressive adenosine in cancer
Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.86 · Cited by 867
Metadata
- Authors
- Novitskiy, S. V., Ryzhov, S., Zaynagetdinov, R., Goldstein, A. E., Huang, Y., Tikhomirov, O. Y., Blackburn, M. R., Biaggioni, I., Carbone, D. P., Feoktistov, I., & Dikov, M. M.
- Affiliations
- Division of Hematology/Oncology,
- Department of Medicine,
- Vanderbilt University (US)
- Department of Biochemistry and Molecular Biology, University of Texas-Houston Medical School
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2008-09-01
- Volume
- 112
- Issue
- 5
- Pages
- 1822-1831
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC2518889
- OpenAlex
- W1981552113
- Cited by
- 430
- References
- 44
- Citations by year
- 2026: 17 · 2025: 18 · 2024: 28 · 2023: 40 · 2022: 33 · 2021: 33 · 2020: 43 · 2019: 23 · 2018: 24 · 2017: 27 · 2016: 17 · 2015: 13 · 2014: 24 · 2013: 18 · 2012: 18
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Histiocytosis Association
- Vanderbilt University
- Vanderbilt-Ingram Cancer Center (5P30-CA068485, CA100562, CA068485)
- National Institutes of Health (CA-068485)
- National Heart, Lung, and Blood Institute (R01HL070952, HL70952, R01HL076306, R01HL070073, HL76306)
- National Cancer Institute (R01CA100562, CA76321, R01CA076321, CA100562, P30CA068485)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- adenosine receptors, adenosine A2B receptor, dendritic cell differentiation, myeloid dendritic cells, adenosine signaling, monocytes, peritoneal macrophages, hematopoietic progenitor cells, tumor microenvironment, hypoxia, allostimulatory activity, angiogenic factors, immunosuppression, tumor growth, vascular endothelial growth factor, IDO, TGF-beta
- MeSH terms
- Adenosine, Adenosine Deaminase, Animals, Base Sequence, Cell Differentiation, Dendritic Cells, Humans, Immune Tolerance, Male, Mice, Inbred C57BL, Neoplasms, Experimental, Neovascularization, Pathologic, Signal Transduction, DNA Primers, Receptors, Purinergic P1, Mice, Knockout, Inflammation Mediators, Receptor, Adenosine A2B, Mice, Purinergic P1 Receptor Antagonists, Adenosine A2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review